News

On October 11, Yale Center for Immuno-Oncology hosted its second annual Dean's Symposium at Harkness Auditorium at the Yale School of Medicine.

At their most basic level, many of the deadliest diseases are caused by nests of misguided proteins. Most medicines work by attaching themselves to these proteins and temporarily shutting them down. In the 1990s, Yale University scientist Craig Crews and a colleague had a radical idea: What if a drug could destroy a bad protein by making it a target of the body’s own molecular trash disposal machines?

Prof Roy Herbst speaks to ecancer at ESMO 2019 in Barcelona about the association between tTMB and clinical outcomes with pembrolizumab alone in PD-L1-positive advanced NSCLC in the KEYNOTE-010 and -042 trials.

Yale Cancer Center (YCC) researchers were awarded a $3.8 million grant from the National Cancer Institute to develop a new cytokine-based immunotherapy for melanoma.

A spike in reported vaping illnesses this past summer has put the focus of attention on vaping from health departments, political pundits and numerous news outlets across the country. All of them seem to be attempting to make sense of and differentiate between vaping, cigarettes and tainted THC cartridges.

Yale School of Medicine’s Valentina Greco and Marina R. Picciotto are among the 11 recipients of the National Institutes of Health’s Pioneer Award, which recognizes scientists who have a history of creative research and who show promise in originating “pioneering approaches to major challenges.” Greco and Picciotto will each receive $3.5 million dollars of funding over the course of five years. In addition, four young Yale scientists will receive the NIH’s Innovator Award.

According to new findings by Yale Cancer Center scientists, higher levels of genetic mutations in a tumor biopsy are linked to improved clinical outcomes in patients using pembrolizumab (Keytruda) to treat non-small cell lung cancer (NSCLC). The findings were presented today at the European Society for Medical Oncology (ESMO) conference in Barcelona, Spain.

Department of Pediatrics appoints Leonel Rodriguez, MD as Section Chief for Gastroenterology/Hepatology and Elijah Paintsil, MD as Section Chief for Infectious Diseases and Global Health

Marina Picciotto, PhD, Charles B.G. Murphy Professor of Psychiatry and Professor in the Child Study Center, of Neuroscience and of Pharmacology, was a guest on the Australian television news program Planet America. She discussed the science around the recent outbreak of vaping-related illnesses on an episode titled, "What's Killing America's Vapers?"